Where does Sanofi rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Sanofi ranks #612 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Sanofi hold?

Sanofi holds 721 US utility patents granted between 2015 and 2025, spanning 67 technology areas.

What is Sanofi's Innovation Score?

Sanofi has an Innovation Score of 66.5 out of 100 (top 1% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Sanofi's patent grant rate increasing or decreasing?

Sanofi's recent grant velocity is -2% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Sanofi's patents?

Sanofi's patents average 17.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Sanofi patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Sanofi

Q: What technology areas does Sanofi focus on?

Sanofi's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 299 patents. Grants appear in 67 CPC subclasses total.

USPTO PatentsView assignee record - 721 granted patents across 67 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Sanofi ranks #612 of 49,997 tracked US assignees by granted-patent volume, with 721 patents across 67 technology areas.

#612
of 49,997 US assignees by volume: Top 1%
by Innovation Score (66.5/100): 17.2
avg claims per patent: -2%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R612 · Foreign Corporation #612 · 721 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-MID 721 grants
TOP-DECILE #612/49,997
PHOTO-FINISH Council OF Scientifi…
CPC-WIDE A61P · 67 areas
INNOV-STRONG 66.5/100
CLAIMS-RICH 17.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT -2% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Council OF Scientific AND Industrial Research (±1 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Rockwell Collins · near

67
Tmeic · near

67
Sanofi · this assignee

67
Sony OF America · near

67
Thales Canada · near

67
3D Lighting… · lowest

7

What this shows Sanofi's Innovation Score is 66.5/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

How Sanofi's grant cadence moved

Between 2020–2024, Sanofi received 319 grants versus 324 in 2015–2019 (-2% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2023 at 81 grants and bottomed in 2021 at 44. Lead class A61P accounts for 41.5% of the portfolio across 67 subclasses. Volume neighbours: TCL China Star Optoelectronics Technology Co., Ltd. (#608) and Dana-farber Cancer Institute, Inc. (#616).

Sanofi's three-year grant acceleration

From 2019–2021 to 2022–2024, Sanofi moved from 171 to 217 grants (1.27x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #684. See the growth leaderboard.

TCL China Star Op…

728
ST Jude Medical C…

727
Exxonmobil Resear…

724
Seoul Viosys

723
Sanofi ◀

721
Council OF Scient…

720
Hoya

718
Roku

717
Dana-farber Cance…

716

What this shows Sanofi holds 721 patents at rank #612, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Sanofi

By rank, the assignees closest to #612 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Sanofi's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Sanofi, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (67 here).

Sony Corporation OF America 67 Rockwell Collins, Inc. 67 Tmeic Corporation 67 Thales Canada Inc. 67

Similar claim depth

Nearest assignees by average claims per patent (17.2 here).

Stryker Corporation 17.2 avg Coopervision International Limited 17.2 avg Clemson University Research Foundation 17.2 avg Suunto Oy 17.2 avg

Sanofi's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

67 Top 1% higher than 99% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Sanofi patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	78	10.8%
2016	55	7.6%
2017	65	9.0%
2018	57	7.9%
2019	69	9.6%
2020	58	8.0%
2021	44	6.1%
2022	57	7.9%
2023	81	11.2%
2024	79	11.0%
2025partial year	78	10.8%

Which technologies does Sanofi patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 299

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 274

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 229

C07D - Heterocyclic Compounds 158

C07K - Peptides 146

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 41

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 40

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 35

Y02A - Technologies FOR Adaptation TO Climate Change 28

C07C - Acyclic OR Carbocyclic Compounds 20

A61B - DIAGNOSIS; SURGERY; Identification 16

C12Y - Enzymes 13

G06F - Electric Digital Data Processing 13

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 12

G06N - Computing Arrangements Based ON Specific Computational Models 10

Top 15 of 67 technology areas

Where it ranks

Overall rank by patents

#612

of 49,997 tracked assignees

Innovation Score

66.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Sanofi's patent record in context - here's where to go next.

Sanofi's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 41.5% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #612 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Sanofi against TCL China Star Optoelectronics Technology Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 66.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.